BioAge Labs Inc.

XNAS:BIOA

20.73

+0.75 (+3.75%)

6:32:38 PM EDT: $20.81 +0.08 (+0.39%)

Market Cap (Intraday)	865.50M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$1.14 Million
Adjusted EPS	-$0.76

See more estimates

10-Day MA	$19.81
50-Day MA	$15.19
200-Day MA	$7.61

See more pivots

BioAge Labs Inc. Stock, XNAS:BIOA

1445A South 50th Street, Richmond, California 94804

United States of America

Phone: +1.510.806.1445

Number of Employees:

http://www.bioagelabs.com

Description

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Richmond, CA.